can i get pregnant on tirzepatide the new diabetes and weight loss drugs affect reproductive health? — Those Nerdy Girls Tirzepatide and Fertility: Weight Loss

However, emerging concerns have been raised regarding their association with acute pancreatitis

Amgens MariTide leads the GLP-1 obesity therapy market in 2025 with innovative design, Phase-3 trials, and strong potential for effective weight loss.

To date, few immediate allergic reactions due to GLP-1 receptor agonists were reported

As these drugs spread to younger and healthier people, a clinical guide tries to replace one-size-fits-all prescribing with something more honest about risk, goals, and how patients are treated.

Modern compoundingoften referred to as 503Ais a niche business, providing patient-specific formulations to satisfy individual needs

We found that GLP-1 receptor agonists were associated with a lower risk of age-related macular degeneration (especially dry AMD) in adults with diabetes and obesity compared with metformin or other weight-loss medications